Joachim P. Steinbach

13.4k total citations · 2 hit papers
159 papers, 6.7k citations indexed

About

Joachim P. Steinbach is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Joachim P. Steinbach has authored 159 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Genetics, 57 papers in Pulmonary and Respiratory Medicine and 44 papers in Molecular Biology. Recurrent topics in Joachim P. Steinbach's work include Glioma Diagnosis and Treatment (107 papers), Brain Metastases and Treatment (50 papers) and Cancer, Hypoxia, and Metabolism (22 papers). Joachim P. Steinbach is often cited by papers focused on Glioma Diagnosis and Treatment (107 papers), Brain Metastases and Treatment (50 papers) and Cancer, Hypoxia, and Metabolism (22 papers). Joachim P. Steinbach collaborates with scholars based in Germany, Switzerland and United States. Joachim P. Steinbach's co-authors include Michael Weller, Guido Reifenberger, Matthias Simon, Wolfgang Wick, Oliver Bähr, Johannes Rieger, Elke Hattingen, Torsten Pietsch, Michael Ronellenfitsch and Andreas von Deimling and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Joachim P. Steinbach

154 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

2012 769 citations Wolfgang Wick, Michael Platten et al. profile →
Long-term survival with glioblastoma multiforme

2007 676 citations Dietmar Krex, Christian Hartmann et al. profile →

Peers

Countries citing papers authored by Joachim P. Steinbach

Since Specialization

Citations

This map shows the geographic impact of Joachim P. Steinbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim P. Steinbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim P. Steinbach more than expected).

Fields of papers citing papers by Joachim P. Steinbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim P. Steinbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim P. Steinbach. The network helps show where Joachim P. Steinbach may publish in the future.

Co-authorship network of co-authors of Joachim P. Steinbach

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim P. Steinbach. A scholar is included among the top collaborators of Joachim P. Steinbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim P. Steinbach. Joachim P. Steinbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma 2025 ·Clinical Nuclear Medicine ·(unknown), Sebastian E. Serfling, (unknown), Philipp E. Hartrampf, Takahiro Higuchi, Matthias Scheich, Stephan Hackenberg, Andreas K. Buck, Joachim P. Steinbach, Rudolf A. Werner, (unknown), Marinela Augustin	1
2	Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death 2024 ·Cell Death Discovery ·(unknown), Nadja I. Lorenz, (unknown), Kevin Klann, Anna‐Luisa Luger, Hans Urban, (unknown), Joachim P. Steinbach, Christian Münch, Michael Ronellenfitsch	3
3	DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastoma 2024 ·Clinical Epigenetics ·(unknown), Philipp Jurmeister, (unknown), Pia S. Zeiner, Joachim P. Steinbach, Tim R. Fenton, Karl H. Plate, Marcus Czabanka, Patrick N. Harter, Katharina J. Weber	0
4	Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1 2024 ·Cell Death Discovery ·(unknown), F Straßheimer, (unknown), (unknown), Hans Urban, (unknown), Stephanie Hehlgans, Joachim P. Steinbach, Michael Ronellenfitsch, Anna‐Luisa Luger	7
5	Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers. 2023 ·Journal of Clinical Oncology ·Juanita Lopez, Simon Haefliger, Ruth Plummer, Paul M. Clément, Heinz Läubli, Patrick Roth, T.R. Jeffry Evans, Lucy Brazil, Ghazaleh Tabatabai, Antje Wick, (unknown), Benjamin Wunderlich, (unknown), Joel R. Eisner, Marc Engelhardt, Thomas Kaindl, Heidi A. Lane, Peter Hau, Thomas Hundsberger, Joachim P. Steinbach	1
6	P06.05.A INTRACEREBROVENTRICULAR TCR-TRANSGENIC T CELL THERAPY TO TREAT GLIOBLASTOMA (INVENT4GB) 2023 ·Neuro-Oncology ·Lukas Bunse, (unknown), (unknown), Khwab Sanghvi, (unknown), Richard P. Harbottle, Stefan B. Eichmüller, Axel Benner, (unknown), Isabel Poschke, Patrick Schmidt, Joachim P. Steinbach, Peter Vajkoczy, Lars Bullinger, Ghazaleh Tabatabai, (unknown), Halvard Bönig, Wolfgang Wick, Michael Platten	1
7	Concurrent CNS tumors and multiple sclerosis: retrospective single-center cohort study and lessons for the clinical management 2022 ·Neurological Sciences ·Yavor Yalachkov, (unknown), Katharina J. Wenger, Marie-Thérèse Forster, Joachim P. Steinbach, Martin Voß	1
8	Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner 2022 ·Cell Death Discovery ·(unknown), Kevin Klann, Jonas B. Michaelis, (unknown), Joachim P. Steinbach, Christian Münch, Michael Ronellenfitsch	8
9	Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients 2022 ·Current Oncology ·(unknown), (unknown), (unknown), Jan Stratmann, Martin Sebastian, Maximilian Rauch, Robert Wolff, Joachim P. Steinbach, Michael Ronellenfitsch, Hans Urban	1
10	Chemotherapy for adult patients with spinal cord gliomas 2021 ·Neuro-Oncology Practice ·Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, Oliver Bähr, Manfred Westphal, Gabriele Schackert, Jörg C. Tonn, Ulrich Herrlinger, Markus Loeffler, Torsten Pietsch, Joachim P. Steinbach, Guido Reifenberger, Patrick Roth, Michael Weller	4
11	Single-shot bevacizumab for cerebral radiation injury 2021 ·BMC Neurology ·Martin Voß, Katharina J. Wenger, Emmanouil Fokas, Marie-Thérèse Forster, Joachim P. Steinbach, Michael Ronellenfitsch	13
12	Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas 2020 ·American Journal of Neuroradiology ·Katharina J. Wenger, Joachim P. Steinbach, Oliver Bähr, Ulrich Pilatus, Elke Hattingen	10
13	Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial 2020 ·Cancers ·Katharina J. Wenger, Marlies Wagner, Patrick N. Harter, Kea Franz, Jörg Bojunga, Emmanouil Fokas, Detlef Imhoff, Claus Rödel, Johannes Rieger, Elke Hattingen, Joachim P. Steinbach, Ulrich Pilatus, Martin Voß	16
14	Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab 2019 ·Journal of Clinical Medicine ·Martin Voß, (unknown), Eike Steidl, Marlies Wagner, Marie-Thérèse Forster, Joachim P. Steinbach, Claus Rödel, Jörg Bojunga, Michael Ronellenfitsch	2
15	Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation 2019 ·Journal of Neuro-Oncology ·(unknown), Julia Tichy, (unknown), Joachim P. Steinbach, Michel Mittelbronn, Marlies Wagner, Christian Foerch	10
16	Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma 2018 ·Acta Neuropathologica Communications ·Michael Ronellenfitsch, Pia S. Zeiner, Michel Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim P. Steinbach, Manfred Westphal, Patrick N. Harter	22
17	Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern 2017 ·International Journal of Molecular Sciences ·Michael C. Burger, Iris Mildenberger, Marlies Wagner, Michel Mittelbronn, Joachim P. Steinbach, Oliver Bähr	6
18	In vivo Metabolic Profiles as Determined by 31P and short TE 1H MR-Spectroscopy 2017 ·Clinical Neuroradiology ·Katharina J. Wenger, Elke Hattingen, Kea Franz, Joachim P. Steinbach, Oliver Bähr, Ulrich Pilatus	19
19	Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network 2009 ·Journal of Clinical Oncology ·Michael Weller, Jörg Felsberg, Christian Hartmann, Hilmar Berger, Joachim P. Steinbach, Johannes Schramm, Manfred Westphal, Gabriele Schackert, Matthias Simon, Jörg C. Tonn, Oliver Heese, Dietmar Krex, Guido Nikkhah, Torsten Pietsch, Otmar D. Wiestler, Guido Reifenberger, Andreas von Deimling, Markus Loeffler	476
20	UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma 2005 ·Journal of Neuro-Oncology ·Ulrich Herrlinger, Johannes Rieger, Joachim P. Steinbach, T. N�gele, J. Dichgans, Michael Weller	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact